- Home
- NUS vs INNV Comparison
NUS vs INNV Comparison
Compare NUS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- INNV
- Stock Information
- Founded
- NUS 1984
- INNV 2007
- Country
- NUS United States
- INNV United States
- Employees
- NUS N/A
- INNV N/A
- Industry
- NUS Other Pharmaceuticals
- INNV Medical/Nursing Services
- Sector
- NUS Health Care
- INNV Health Care
- Exchange
- NUS Nasdaq
- INNV Nasdaq
- Market Cap
- NUS 440.8M
- INNV 527.9M
- IPO Year
- NUS 1996
- INNV 2021
- Fundamental
- Price
- NUS $9.14
- INNV $4.07
- Analyst Decision
- NUS Hold
- INNV Sell
- Analyst Count
- NUS 2
- INNV 2
- Target Price
- NUS $6.88
- INNV $5.00
- AVG Volume (30 Days)
- NUS 507.1K
- INNV 46.1K
- Earning Date
- NUS 08-07-2025
- INNV 09-09-2025
- Dividend Yield
- NUS 2.61%
- INNV N/A
- EPS Growth
- NUS N/A
- INNV N/A
- EPS
- NUS N/A
- INNV N/A
- Revenue
- NUS $1,679,268,000.00
- INNV $831,683,000.00
- Revenue This Year
- NUS N/A
- INNV $13.77
- Revenue Next Year
- NUS N/A
- INNV $10.12
- P/E Ratio
- NUS N/A
- INNV N/A
- Revenue Growth
- NUS N/A
- INNV 12.19
- 52 Week Low
- NUS $5.32
- INNV $2.60
- 52 Week High
- NUS $11.64
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- NUS 72.17
- INNV 52.67
- Support Level
- NUS $7.86
- INNV $4.13
- Resistance Level
- NUS $8.16
- INNV $4.41
- Average True Range (ATR)
- NUS 0.34
- INNV 0.24
- MACD
- NUS 0.12
- INNV 0.01
- Stochastic Oscillator
- NUS 92.79
- INNV 55.17
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.